TY - JOUR
T1 - Role of CAMK2D in neurodevelopment and associated conditions
AU - Rigter, Pomme M.F.
AU - de Konink, Charlotte
AU - Dunn, Matthew J.
AU - Proietti Onori, Martina
AU - Humberson, Jennifer B.
AU - Thomas, Matthew
AU - Barnes, Caitlin
AU - Prada, Carlos E.
AU - Weaver, K. Nicole
AU - Ryan, Thomas D.
AU - Caluseriu, Oana
AU - Conway, Jennifer
AU - Calamaro, Emily
AU - Fong, Chin To
AU - Wuyts, Wim
AU - Meuwissen, Marije
AU - Hordijk, Eva
AU - Jonkers, Carsten N.
AU - Anderson, Lucas
AU - Yuseinova, Berfin
AU - Polonia, Sarah
AU - Beysen, Diane
AU - Stark, Zornitza
AU - Savva, Elena
AU - Poulton, Cathryn
AU - McKenzie, Fiona
AU - Bhoj, Elizabeth
AU - Bupp, Caleb P.
AU - Bézieau, Stéphane
AU - Mercier, Sandra
AU - Blevins, Amy
AU - Wentzensen, Ingrid M.
AU - Xia, Fan
AU - Rosenfeld, Jill A.
AU - Hsieh, Tzung Chien
AU - Krawitz, Peter M.
AU - Elbracht, Miriam
AU - Veenma, Danielle C.M.
AU - Schulman, Howard
AU - Stratton, Margaret M.
AU - Küry, Sébastien
AU - van Woerden, Geeske M.
N1 - We would like to thank the families of the affected individuals described in this paper for their help and their willingness to contribute to this study. This research was supported by the NWO-VIDI (016.Vidi.188.014 to G.M.v.W.). Individual 8 was tested as part of the Acute Care Genomics study (GHFM76747). G.M.v.W. S.K. M.M.S. and D.C.M.V. designed the study. P.M.F.R. C.d.K. M.J.D. M.P.O. E.H. C.N.J. L.A. B.Y. S.P. M.M.S. and G.M.v.W. performed functional experiments and analysis. T.-C.H. P.M.K. and M.E. performed the facial analysis. A.B. and I.M.W. performed analysis and reporting of GeneDx cases, J.A.R. and F.X. handled the Baylor Genetics cases. S.K. J.B.H. M.T. C.B. C.E.P. K.N.W. T.D.R. O.C. J.C. E.C. C.-T.F. W.W. M.M. D.B. Z.S. E.S. C.P. F.M. E.B. C.P.B. S.B. and S.M. were involved in case identification and/or data collection and contributed to the clinical information of patients. P.M.F.R. C.d.K. M.M.S. S.K. H.S. and G.M.v.W. drafted the manuscript. All authors contributed to the final version of the manuscript. The Department of Molecular and Human Genetics at Baylor College of Medicine receives revenue from clinical genetic testing completed at Baylor Genetics Laboratories. A.B. and I.M.W. are employees of GeneDx, LLC; H.S. is a consultant for Vasa Therapeutics (Poland).
Publisher Copyright:
© 2023 American Society of Human Genetics
PY - 2024/1/24
Y1 - 2024/1/24
N2 - The calcium/calmodulin-dependent protein kinase type 2 (CAMK2) family consists of four different isozymes, encoded by four different genes—CAMK2A, CAMK2B, CAMK2G, and CAMK2D—of which the first three have been associated recently with neurodevelopmental disorders. CAMK2D is one of the major CAMK2 proteins expressed in the heart and has been associated with cardiac anomalies. Although this CAMK2 isoform is also known to be one of the major CAMK2 subtypes expressed during early brain development, it has never been linked with neurodevelopmental disorders until now. Here we show that CAMK2D plays an important role in neurodevelopment not only in mice but also in humans. We identified eight individuals harboring heterozygous variants in CAMK2D who display symptoms of intellectual disability, delayed speech, behavioral problems, and dilated cardiomyopathy. The majority of the variants tested lead to a gain of function (GoF), which appears to cause both neurological problems and dilated cardiomyopathy. In contrast, loss-of-function (LoF) variants appear to induce only neurological symptoms. Together, we describe a cohort of individuals with neurodevelopmental disorders and cardiac anomalies, harboring pathogenic variants in CAMK2D, confirming an important role for the CAMK2D isozyme in both heart and brain function.
AB - The calcium/calmodulin-dependent protein kinase type 2 (CAMK2) family consists of four different isozymes, encoded by four different genes—CAMK2A, CAMK2B, CAMK2G, and CAMK2D—of which the first three have been associated recently with neurodevelopmental disorders. CAMK2D is one of the major CAMK2 proteins expressed in the heart and has been associated with cardiac anomalies. Although this CAMK2 isoform is also known to be one of the major CAMK2 subtypes expressed during early brain development, it has never been linked with neurodevelopmental disorders until now. Here we show that CAMK2D plays an important role in neurodevelopment not only in mice but also in humans. We identified eight individuals harboring heterozygous variants in CAMK2D who display symptoms of intellectual disability, delayed speech, behavioral problems, and dilated cardiomyopathy. The majority of the variants tested lead to a gain of function (GoF), which appears to cause both neurological problems and dilated cardiomyopathy. In contrast, loss-of-function (LoF) variants appear to induce only neurological symptoms. Together, we describe a cohort of individuals with neurodevelopmental disorders and cardiac anomalies, harboring pathogenic variants in CAMK2D, confirming an important role for the CAMK2D isozyme in both heart and brain function.
KW - calcium/calmodulin-dependent protein kinase 2 delta
KW - CAMK2D
KW - cardiomyopathy
KW - intellectual disability
KW - neurodevelopment
UR - http://www.scopus.com/inward/record.url?scp=85183503717&partnerID=8YFLogxK
U2 - 10.1016/j.ajhg.2023.12.016
DO - 10.1016/j.ajhg.2023.12.016
M3 - Article
C2 - 38272033
AN - SCOPUS:85183503717
SN - 0002-9297
VL - 111
SP - 364
EP - 382
JO - American Journal of Human Genetics
JF - American Journal of Human Genetics
IS - 2
ER -